Pharmacotherapy of low back pain: targeting nociceptive and neuropathic pain components

References

• Petersen-Felix S, Curatolo M. Neuroplasticity – an important factor in acute and chronic pain. Swiss Med Wkly 2002;132:273-8
   PubMed Web of Science ®Google Scholar
• Davis MP. What is new in neuropathic pain? Support Care Cancer 2007;15:363-72
   PubMed Web of Science ®Google Scholar
• Costigan M, Scholz J, Woolf CJ. Neuropathic pain: a maladaptive response of the nervous system to damage. Annu Rev Neurosci 2009;32:1-32
   PubMed Web of Science ®Google Scholar
• Bee LA, Dickenson AH. Descending facilitation from the brainstem determines behavioural and neuronal hypersensitivity following nerve injury and efficacy of pregabalin. Pain 2008;140:209-23
   PubMed Web of Science ®Google Scholar
• Vera-Portocarrero LP, Zhang ET, Ossipov MH, et al. Descending facilitation from the rostral ventromedial medulla maintains nerve injury-induced central sensitization. Neuroscience 2006;140:1311-20
   PubMed Web of Science ®Google Scholar
• Kohno T, Ji RR, Ito N, et al. Peripheral axonal injury results in reduced mu opioid receptor pre- and post-synaptic action in the spinal cord. Pain 2005;117:77-87
   PubMed Web of Science ®Google Scholar
• World Health Organization. International Classification of Functioning, Disability and Health 2000
   Google Scholar
• Deyo RA, Mirza SK, Martin BI. Back pain prevalence and visit rates: estimates from U.S. national surveys, 2002. Spine (Phila Pa 1976) 2006;31:2724-7
   PubMed Web of Science ®Google Scholar
• Neuhauser H, Ellert U, Ziese T. [Chronic back pain in the general population in Germany 2002/2003: prevalence and highly affected population groups]. Gesundheitswesen 2005;67:685-93
   PubMed Web of Science ®Google Scholar
• Webb R, Brammah T, Lunt M, et al. Prevalence and predictors of intense, chronic, and disabling neck and back pain in the UK general population. Spine (Phila Pa 1976) 2003;28:1195-202
   PubMed Web of Science ®Google Scholar
• Kroenke K, Krebs EE, Bair MJ. Pharmacotherapy of chronic pain: a synthesis of recommendations from systematic reviews. Gen Hosp Psychiatry 2009;31:206-19
   PubMed Web of Science ®Google Scholar
• van Tulder MW, Assendelft WJ, Koes BW, et al. Spinal radiographic findings and nonspecific low back pain. A systematic review of observational studies. Spine (Phila Pa 1976) 1997;22:427-34
   PubMed Web of Science ®Google Scholar
• Deyo RA, Weinstein JN. Low back pain. N Engl J Med 2001;344:363-70
   PubMed Web of Science ®Google Scholar
• Freynhagen R, Baron R. The evaluation of neuropathic components in low back pain. Curr Pain Headache Rep 2009;13:185-90
   PubMed Web of Science ®Google Scholar
• Forde G. Adjuvant analgesics for the treatment of neuropathic pain: evaluating efficacy and safety profiles. J Fam Pract 2007;56:3-12
   PubMed Web of Science ®Google Scholar
• Woolf CJ. Pain: moving from symptom control toward mechanism-specific pharmacologic management. Ann Intern Med 2004;140:441-51
   PubMed Web of Science ®Google Scholar
• Freynhagen R, Baron R, Gockel U, et al. painDETECT: a new screening questionnaire to identify neuropathic components in patients with back pain. Curr Med Res Opin 2006;22:1911-20
   PubMed Web of Science ®Google Scholar
• Freynhagen R, Baron R, Tolle T, et al. Screening of neuropathic pain components in patients with chronic back pain associated with nerve root compression: a prospective observational pilot study (MIPORT). Curr Med Res Opin 2006;22:529-37
   PubMed Web of Science ®Google Scholar
• Hassan AE, Saleh HA, Baroudy YM, et al. Prevalence of neuropathic pain among patients suffering from chronic low back pain in Saudi Arabia. Saudi Med J 2004;25:1986-90
   PubMed Web of Science ®Google Scholar
• Kaki AM, El-Yaski AZ, Youseif E. Identifying neuropathic pain among patients with chronic low-back pain: use of the Leeds Assessment of Neuropathic Symptoms and Signs pain scale. Reg Anesth Pain Med 2005;30:422-8
   PubMed Web of Science ®Google Scholar
• Schmidt CO, Schweikert B, Wenig CM, et al. Modelling the prevalence and cost of back pain with neuropathic components in the general population. Eur J Pain 2009;13:1030-5
   PubMed Web of Science ®Google Scholar
• Chou R, Huffman LH. Medications for acute and chronic low back pain: a review of the evidence for an American Pain Society/American College of Physicians clinical practice guideline. Ann Intern Med 2007;147:505-14
   PubMed Web of Science ®Google Scholar
• Chou R, Huffman LH. Nonpharmacologic therapies for acute and chronic low back pain: a review of the evidence for an American Pain Society/American College of Physicians clinical practice guideline. Ann Intern Med 2007;147:492-504
   PubMed Web of Science ®Google Scholar
• Savigny P, Kuntze S, Watson P, et al. Low Back Pain: Early Management of Persistent Non-Specific Low Back Pain. London: National Collaborating Centre for Primary Care and Royal College of General Practitioners, 2009
   Google Scholar
• Savigny P, Watson P, Underwood M. Early management of persistent non-specific low back pain: summary of NICE guidance. BMJ 2009;338:b1805
   PubMed Web of Science ®Google Scholar
• Gilron I, Max MB. Combination pharmacotherapy for neuropathic pain: current evidence and future directions. Expert Rev Neurother 2005;5:823-30
   PubMedGoogle Scholar
• Varrassi G, Muller-Schwefe G, Pergolizzi J, et al. Pharmacological treatment of chronic pain – the need for CHANGE. Curr Med Res Opin 2010;26:1231-45
   PubMed Web of Science ®Google Scholar
• European Medicines Agency. ICH Topic E 6 (R1) Guideline for Good Clinical Practice, Step 5. 2002. Available at: http://www.ema.europa.eu/docs/en_GB/document_library/Scientific_guideline/2009/09/WC500002874.pdf [Last accessed 20 October 2010]
   Google Scholar
• Cohen SP, Argoff CE, Carragee EJ. Management of low back pain. BMJ 2008;337:a2718
   PubMedGoogle Scholar
• Bennett M. The LANSS Pain Scale: the Leeds assessment of neuropathic symptoms and signs. Pain 2001;92:147-57
   PubMed Web of Science ®Google Scholar
• Treede RD, Jensen TS, Campbell JN, et al. Neuropathic pain: redefinition and a grading system for clinical and research purposes. Neurology 2008;70:1630-5
   PubMed Web of Science ®Google Scholar
• Chopade AR, Mulla WA. Novel strategies for the treatment of inflammatory hyperalgesia. Eur J Clin Pharmacol 2010;66:429-44
   PubMed Web of Science ®Google Scholar
• Arendt-Nielsen L, Graven-Nielsen T. Central sensitization in fibromyalgia and other musculoskeletal disorders. Curr Pain Headache Rep 2003;7:355-61
   PubMedGoogle Scholar
• Cruccu G, Truini A. Tools for assessing neuropathic pain. PLoS Med 2009;6:e1000045
   PubMed Web of Science ®Google Scholar
• Krause SJ, Backonja MM. Development of a neuropathic pain questionnaire. Clin J Pain 2003;19:306-14
   PubMed Web of Science ®Google Scholar
• Portenoy R. Development and testing of a neuropathic pain screening questionnaire: ID Pain. Curr Med Res Opin 2006;22:1555-65
   PubMed Web of Science ®Google Scholar
• Bouhassira D, Attal N, Alchaar H, et al. Comparison of pain syndromes associated with nervous or somatic lesions and development of a new neuropathic pain diagnostic questionnaire (DN4). Pain 2005;114:29-36
   PubMed Web of Science ®Google Scholar
• O'Connor AB. Neuropathic pain: quality-of-life impact, costs and cost effectiveness of therapy. Pharmacoeconomics 2009;27:95-112
   PubMed Web of Science ®Google Scholar
• Grabois M. Management of chronic low back pain. Am J Phys Med Rehabil 2005;84:S29-41
   PubMed Web of Science ®Google Scholar
• Chou R, Qaseem A, Snow V, et al. Diagnosis and treatment of low back pain: a joint clinical practice guideline from the American College of Physicians and the American Pain Society. Ann Intern Med 2007;147:478-91
   PubMed Web of Science ®Google Scholar
• Dworkin RH, O'Connor AB, Backonja M, et al. Pharmacologic management of neuropathic pain: evidence-based recommendations. Pain 2007;132:237-51
   PubMed Web of Science ®Google Scholar
• Hayden JA, van Tulder MW, Malmivaara A, et al. Exercise therapy for treatment of non-specific low back pain. Cochrane Database Syst Rev 2005:CD000335
   Google Scholar
• Choi BK, Verbeek JH, Tam WW, et al. Exercises for prevention of recurrences of low-back pain. Cochrane Database Syst Rev 2010:CD006555
   Google Scholar
• Heymans MW, van Tulder MW, Esmail R, et al. Back schools for non-specific low-back pain. Cochrane Database Syst Rev 2004:CD000261
   Google Scholar
• Indahl A, Haldorsen EH, Holm S, et al. Five-year follow-up study of a controlled clinical trial using light mobilization and an informative approach to low back pain. Spine (Phila Pa 1976) 1998;23:2625-30
   PubMed Web of Science ®Google Scholar
• Indahl A, Velund L, Reikeraas O. Good prognosis for low back pain when left untampered. A randomized clinical trial. Spine (Phila Pa 1976) 1995;20:473-7
   PubMed Web of Science ®Google Scholar
• Graham GG, Scott KF. Mechanisms of action of paracetamol and related analgesics. Inflammopharmacology 2003;11:401-13
   PubMedGoogle Scholar
• Pickering G, Esteve V, Loriot MA, et al. Acetaminophen reinforces descending inhibitory pain pathways. Clin Pharmacol Ther 2008;84:47-51
   PubMed Web of Science ®Google Scholar
• Cashman JN. The mechanisms of action of NSAIDs in analgesia. Drugs 1996;52(Suppl. 5):13-23
   PubMed Web of Science ®Google Scholar
• Laine L. Nonsteroidal anti-inflammatory drug gastropathy. Gastrointest Endosc Clin N Am 1996;6:489-504
   PubMedGoogle Scholar
• Whelton A. Renal and related cardiovascular effects of conventional and COX-2-specific NSAIDs and non-NSAID analgesics. Am J Ther 2000;7:63-74
   PubMedGoogle Scholar
• Kearney PM, Baigent C, Godwin J, et al. Do selective cyclo-oxygenase-2 inhibitors and traditional non-steroidal anti-inflammatory drugs increase the risk of atherothrombosis? Meta-analysis of randomised trials. BMJ 2006;332:1302-8
   PubMed Web of Science ®Google Scholar
• Bresalier RS, Sandler RS, Quan H, et al. Cardiovascular events associated with rofecoxib in a colorectal adenoma chemoprevention trial. N Engl J Med 2005;352:1092-102
   PubMed Web of Science ®Google Scholar
• Chou R. Pharmacological management of low back pain. Drugs 2010;70:387-402
   PubMed Web of Science ®Google Scholar
• Amer M, Bead VR, Bathon J, et al. Use of nonsteroidal anti-inflammatory drugs in patients with cardiovascular disease: a cautionary tale. Cardiol Rev 2010;18:204-12
   PubMed Web of Science ®Google Scholar
• Singh G. Recent considerations in nonsteroidal anti-inflammatory drug gastropathy. Am J Med 1998;105:31S-8S
   PubMedGoogle Scholar
• American Geriatrics Society Panel on Pharmacological Management of Persistent Pain in Older Persons. Pharmacological management of persistent pain in older persons. J Am Geriatr Soc 2009;57:1331-46
   PubMed Web of Science ®Google Scholar
• Katz N, Ju WD, Krupa DA, et al. Efficacy and safety of rofecoxib in patients with chronic low back pain: results from two 4-week, randomized, placebo-controlled, parallel-group, double-blind trials. Spine (Phila Pa 1976) 2003;28:851-8; discussion 9
   PubMed Web of Science ®Google Scholar
• Katz N, Rodgers DB, Krupa D, et al. Onset of pain relief with rofecoxib in chronic low back pain: results of two four-week, randomized, placebo-controlled trials. Curr Med Res Opin 2004;20:651-8
   PubMed Web of Science ®Google Scholar
• Romano CL, Romano D, Bonora C, et al. Pregabalin, celecoxib, and their combination for treatment of chronic low-back pain. J Orthop Traumatol 2009;10:185-91
   PubMedGoogle Scholar
• Roelofs PD, Deyo RA, Koes BW, et al. Non-steroidal anti-inflammatory drugs for low back pain. Cochrane Database Syst Rev 2008:CD000396
   Google Scholar
• Derry S, Barden J, McQuay HJ, et al. Single dose oral celecoxib for acute postoperative pain in adults. Cochrane Database Syst Rev 2008:CD004233
   Google Scholar
• Acute pain: The Oxford league table of analgesic efficacy. Available at: http://www.medicine.ox.ac.uk/bandolier/Extraforbando/APain.pdf [Last accessed 20 October 2010]
   Google Scholar
• Collett BJ. Chronic opioid therapy for non-cancer pain. Br J Anaesth 2001;87:133-43
   PubMed Web of Science ®Google Scholar
• Furlan AD, Sandoval JA, Mailis-Gagnon A, et al. Opioids for chronic noncancer pain: a meta-analysis of effectiveness and side effects. CMAJ 2006;174:1589-94
   PubMed Web of Science ®Google Scholar
• Moore RA, McQuay HJ. Prevalence of opioid adverse events in chronic non-malignant pain: systematic review of randomised trials of oral opioids. Arthritis Res Ther 2005;7:R1046-51
   PubMed Web of Science ®Google Scholar
• Papaleontiou M, Henderson Jr CR, Turner BJ, et al. Outcomes associated with opioid use in the treatment of chronic noncancer pain in older adults: a systematic review and meta-analysis. J Am Geriatr Soc 2010;58:1353-69
   PubMed Web of Science ®Google Scholar
• Jage J. Opioid tolerance and dependence – do they matter? Eur J Pain 2005;9:157-62
   PubMed Web of Science ®Google Scholar
• Sng BL, Schug SA. The role of opioids in managing chronic non-cancer pain. Ann Acad Med Singapore 2009;38:960-6
   PubMed Web of Science ®Google Scholar
• Deshpande A, Furlan A, Mailis-Gagnon A, et al. Opioids for chronic low-back pain. Cochrane Database Syst Rev 2007:CD004959
   Google Scholar
• Fine PG, Mahajan G, McPherson ML. Long-acting opioids and short-acting opioids: appropriate use in chronic pain management. Pain Med 2009;10(Suppl. 2):S79-88
   PubMedGoogle Scholar
• Kalso E, Simpson KH, Slappendel R, et al. Predicting long-term response to strong opioids in patients with low back pain: findings from a randomized, controlled trial of transdermal fentanyl and morphine. BMC Med 2007;5:39
   PubMed Web of Science ®Google Scholar
• Wasan AD, Davar G, Jamison R. The association between negative affect and opioid analgesia in patients with discogenic low back pain. Pain 2005;117:450-61
   PubMed Web of Science ®Google Scholar
• Wasan AD, Kaptchuk TJ, Davar G, et al. The association between psychopathology and placebo analgesia in patients with discogenic low back pain. Pain Med 2006;7:217-28
   PubMed Web of Science ®Google Scholar
• Hale ME, Ahdieh H, Ma T, et al. Efficacy and safety of OPANA ER (oxymorphone extended release) for relief of moderate to severe chronic low back pain in opioid-experienced patients: a 12-week, randomized, double-blind, placebo-controlled study. J Pain 2007;8:175-84
   PubMed Web of Science ®Google Scholar
• Katz N, Rauck R, Ahdieh H, et al. A 12-week, randomized, placebo-controlled trial assessing the safety and efficacy of oxymorphone extended release for opioid-naive patients with chronic low back pain. Curr Med Res Opin 2007;23:117-28
   PubMed Web of Science ®Google Scholar
• Peniston JH, Gould E. Oxymorphone extended release for the treatment of chronic low back pain: a retrospective pooled analysis of enriched-enrollment clinical trial data stratified according to age, sex, and prior opioid use. Clin Ther 2009;31:347-59
   PubMed Web of Science ®Google Scholar
• Hale ME, Dvergsten C, Gimbel J. Efficacy and safety of oxymorphone extended release in chronic low back pain: results of a randomized, double-blind, placebo- and active-controlled phase III study. J Pain 2005;6:21-8
   PubMed Web of Science ®Google Scholar
• Allan L, Richarz U, Simpson K, et al. Transdermal fentanyl versus sustained release oral morphine in strong-opioid naive patients with chronic low back pain. Spine (Phila Pa 1976) 2005;30:2484-90
   PubMed Web of Science ®Google Scholar
• Khoromi S, Cui L, Nackers L, et al. Morphine, nortriptyline and their combination vs. placebo in patients with chronic lumbar root pain. Pain 2007;130:66-75
   PubMed Web of Science ®Google Scholar
• Gould EM, Jensen MP, Victor TW, et al. The pain quality response profile of oxymorphone extended release in the treatment of low back pain. Clin J Pain 2009;25:116-22
   PubMed Web of Science ®Google Scholar
• Noble M, Treadwell JR, Tregear SJ, et al. Long-term opioid management for chronic noncancer pain. Cochrane Database Syst Rev 2010:CD006605
   Google Scholar
• Raffa RB, Nayak RK, Liao S, et al. The mechanism(s) of action and pharmacokinetics of tramadol hydrochloride. Rev Contemp Pharmacol 1995;6:485-97
   Google Scholar
• Reeves RR, Burke RS. Tramadol: basic pharmacology and emerging concepts. Drugs Today (Barc) 2008;44:827-36
   PubMed Web of Science ®Google Scholar
• World Heath Organization. Cancer Pain Relief. Geneva, 1986
   Google Scholar
• Apaydin S, Uyar M, Karabay NU, et al. The antinociceptive effect of tramadol on a model of neuropathic pain in rats. Life Sci 2000;66:1627-37
   PubMed Web of Science ®Google Scholar
• Schnitzer TJ, Gray WL, Paster RZ, et al. Efficacy of tramadol in treatment of chronic low back pain. J Rheumatol 2000;27:772-8
   PubMed Web of Science ®Google Scholar
• Verdu B, Decosterd I, Buclin T, et al. Antidepressants for the treatment of chronic pain. Drugs 2008;68:2611-32
   PubMed Web of Science ®Google Scholar
• Salerno SM, Browning R, Jackson JL. The effect of antidepressant treatment on chronic back pain: a meta-analysis. Arch Intern Med 2002;162:19-24
   PubMed Web of Science ®Google Scholar
• Staiger TO, Gaster B, Sullivan MD, et al. Systematic review of antidepressants in the treatment of chronic low back pain. Spine (Phila Pa 1976) 2003;28:2540-5
   PubMed Web of Science ®Google Scholar
• Urquhart DM, Hoving JL, Assendelft WW, et al. Antidepressants for non-specific low back pain. Cochrane Database Syst Rev 2008:CD001703, page 2
   Google Scholar
• Katz J, Pennella-Vaughan J, Hetzel RD, et al. A randomized, placebo-controlled trial of bupropion sustained release in chronic low back pain. J Pain 2005;6:656-61
   PubMed Web of Science ®Google Scholar
• Skljarevski V, Ossanna M, Liu-Seifert H, et al. A double-blind, randomized trial of duloxetine versus placebo in the management of chronic low back pain. Eur J Neurol 2009;16:1041-8
   PubMed Web of Science ®Google Scholar
• Skljarevski V, Zhang S, Desaiah D, et al. Duloxetine versus placebo in patients with chronic low back pain: a 12-week, fixed-dose, randomized, double-blind trial. J Pain 2010: published online 15 May 2010, doi:10.1016/j.jpain.2010.03.002
   Google Scholar
• Skljarevski V, Desaiah D, Lin-Seifert H. Efficacy of duloxetine in chronic low back pain. Eur Neurol 2008;15:320
   Web of Science ®Google Scholar
• Skljarevski V, Zhang S, Chappell AS, et al. Maintenance of effect of duloxetine in patients with chronic low back pain: a 41-week uncontrolled, dose-blinded study. Pain Med 2010;11:648-57
   PubMed Web of Science ®Google Scholar
• Dickens C, Jayson M, Sutton C, et al. The relationship between pain and depression in a trial using paroxetine in sufferers of chronic low back pain. Psychosomatics 2000;41:490-9
   PubMed Web of Science ®Google Scholar
• Ferguson JM. SSRI antidepressant medications: adverse effects and tolerability. Prim Care Companion J Clin Psychiatry 2001;3:22-7
   PubMedGoogle Scholar
• Sills GJ. The mechanisms of action of gabapentin and pregabalin. Curr Opin Pharmacol 2006;6:108-13
   PubMed Web of Science ®Google Scholar
• Remmers AE, Sharma U, Lamoreaux L, et al. Pregabalin treatment of patients with chronic low back pain. Abstract 660. Proceedings of the 19th Annual Meeting of the American Pain Society 2000. Atlanta, Georgia, 2000
   Google Scholar
• Gatti A, Sabato AF, Occhioni R, et al. Controlled-release oxycodone and pregabalin in the treatment of neuropathic pain: results of a multicenter Italian study. Eur Neurol 2009;61:129-37
   PubMed Web of Science ®Google Scholar
• Yaksi A, Ozgonenel L, Ozgonenel B. The efficiency of gabapentin therapy in patients with lumbar spinal stenosis. Spine (Phila Pa 1976) 2007;32:939-42
   PubMed Web of Science ®Google Scholar
• Levendoglu F, Ogun CO, Ozerbil O, et al. Gabapentin is a first line drug for the treatment of neuropathic pain in spinal cord injury. Spine (Phila Pa 1976) 2004;29:743-51
   PubMed Web of Science ®Google Scholar
• Khoromi S, Patsalides A, Parada S, et al. Topiramate in chronic lumbar radicular pain. J Pain 2005;6:829-36
   PubMed Web of Science ®Google Scholar
• Rosielle DA. The lidocaine patch #148. J Palliat Med 2008;11:502-3
   PubMed Web of Science ®Google Scholar
• Gammaitoni AR, Davis MW. Pharmacokinetics and tolerability of lidocaine patch 5% with extended dosing. Ann Pharmacother 2002;36:236-40
   PubMed Web of Science ®Google Scholar
• Levin OS, Moseikin IA. [The use of lidocaine-coated plates (versatis) in the treatment of back pain]. Zh Nevrol Psikhiatr Im S S Korsakova 2009;109:44-50
   Google Scholar
• Gimble J, Hale M, Linn R, et al. Lidocaine patch 5% in patients with acute/subacute and chronic low back pain: Impact on pain intensity, pain relief, and pain interference with quality of life. 22nd Annual Meeting of the American Pain Society. Chicago, IL, 2003
   Google Scholar
• Keitel W, Frerick H, Kuhn U, et al. Capsicum pain plaster in chronic non-specific low back pain. Arzneimittelforschung 2001;51:896-903
   PubMed Web of Science ®Google Scholar
• van Tulder MW, Touray T, Furlan AD, et al. Muscle relaxants for non-specific low back pain. Cochrane Database Syst Rev 2003:CD004252
   Google Scholar
• Matsudaira K, Seichi A, Kunogi J, et al. The efficacy of prostaglandin E1 derivative in patients with lumbar spinal stenosis. Spine (Phila Pa 1976) 2009;34:115-20
   PubMed Web of Science ®Google Scholar
• Tafazal SI, Ng L, Sell P. Randomised placebo-controlled trial on the effectiveness of nasal salmon calcitonin in the treatment of lumbar spinal stenosis. Eur Spine J 2007;16:207-12
   PubMed Web of Science ®Google Scholar
• Waikakul W, Waikakul S. Methylcobalamin as an adjuvant medication in conservative treatment of lumbar spinal stenosis. J Med Assoc Thai 2000;83:825-31
   PubMedGoogle Scholar
• Baron R, Binder A. [How neuropathic is sciatica? The mixed pain concept]. Orthopade 2004;33:568-75
   PubMed Web of Science ®Google Scholar
• Pergolizzi J, Wills LM. Multimodal analgesic therapy. In: Shorten G, Carr DB, Harmon D, eds. Postoperative Pain, an Evidence-based Guide to Practitioners. Philadelphia, PA: Saunders Elsevier, 2006:182-96
   Google Scholar
• Gatti A, Sabato AF, Carucci A, et al. Adequacy assessment of oxycodone/paracetamol (acetaminophen) in multimodal chronic pain: a prospective observational study. Clin Drug Investig 2009;29(Suppl. 1):31-40
   PubMed Web of Science ®Google Scholar
• Pota V, Maisto M, Pace MC, et al. Association of buprenorphine TDS and pregabalin in the treatment of low back pain. Eur J Pain 2007;11:S83
   PubMedGoogle Scholar
• Ruoff GE, Rosenthal N, Jordan D, et al. Tramadol/acetaminophen combination tablets for the treatment of chronic lower back pain: a multicenter, randomized, double-blind, placebo-controlled outpatient study. Clin Ther 2003;25:1123-41
   PubMed Web of Science ®Google Scholar
• Peloso PM, Fortin L, Beaulieu A, et al. Analgesic efficacy and safety of tramadol/acetaminophen combination tablets (Ultracet) in treatment of chronic low back pain: a multicenter, outpatient, randomized, double blind, placebo controlled trial. J Rheumatol 2004;31:2454-63
   PubMed Web of Science ®Google Scholar